NCT00096967View on ClinicalTrials.gov

A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

July 31, 2004

Conditions

Breast CancerColorectal CancerMetastases

Interventions

DRUG

Avastin (bevacizumab)

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY

NCT00096967 - A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study | Biotech Hunter | Biotech Hunter